Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Alexander

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Translational Medicine|July 10, 2025
Spatial profiling reveals unique immune microenvironment in premenopausal triple-negative breast cancer associated with therapy responseVidya P Nimbalkar, V P Snijesh, Savitha Rajarajan, et al.
Translational Oncology|April 21, 2024
Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytesV P Snijesh, Vidya P Nimbalkar, Sharada Patil, et al.
Journal of Cancer|February 25, 2014
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative TumorsJyothi S Prabhu, Aruna Korlimarla, Krisha Desai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cellsKrisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
Translational Oncology|July 14, 2017
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage DiseaseJyothi S Prabhu, Aruna Korlimarla, C E Anupama, et al.
Translational Oncology|August 21, 2023
An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSavitha Rajarajan, V P Snijesh, C E Anupama, et al.
Cancer Medicine|May 18, 2016
High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancersKrisha Desai, Madhumathy G Nair, Jyothi S Prabhu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Translational Medicine|July 10, 2025
Spatial profiling reveals unique immune microenvironment in premenopausal triple-negative breast cancer associated with therapy responseVidya P Nimbalkar, V P Snijesh, Savitha Rajarajan, et al.
Translational Oncology|April 21, 2024
Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytesV P Snijesh, Vidya P Nimbalkar, Sharada Patil, et al.
Journal of Cancer|February 25, 2014
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative TumorsJyothi S Prabhu, Aruna Korlimarla, Krisha Desai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cellsKrisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
Translational Oncology|July 14, 2017
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage DiseaseJyothi S Prabhu, Aruna Korlimarla, C E Anupama, et al.
Translational Oncology|August 21, 2023
An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSavitha Rajarajan, V P Snijesh, C E Anupama, et al.
Cancer Medicine|May 18, 2016
High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancersKrisha Desai, Madhumathy G Nair, Jyothi S Prabhu, et al.
Pageof 2